Dental Education
Online Dental Education Dental education lectures and videos Online dental ce Dental education articles Expert dental educators Dental products education Dental Community
 
Video Details
Autologous Bone vs. Bioactive Modifiers/BMP-2: A Clinical Update in Bone Regeneration - Part 1 of 2

Description:
There are several techniques and materials available for implant site development. The choice may depend on a number of factors including size of the defect, osseous morphology, costs and surgeon or patient preferences. Autogenous bone has long been considered the gold standard of graft materials. The trend today is to reduce patient morbidity but still provide predictable outcomes. This lecture will discuss the use of autogenous bone versus using bioactive modifiers such as platelet concentrates, rhPDGF and rhBMP-2 as replacement for the need to harvest bone.

Date Added:
1/5/2019

Author(s):

Craig M Misch, DDS, MDS Craig M Misch, DDS, MDS
Dr. Craig M. Misch graduated from the University of Michigan School of Dentistry. He then received postgraduate certificates in prosthodontics and oral implantology as well a...
[read more]








Online Videos / Surgery / Bone Grafting / Autologous Bone vs. Bioactive Modifiers/BMP-2: A Clinical Update in Bone Regeneration - Part 1 of 2




Questions & Comments
Patrick Sweeney - (5/14/2019 10:12 PM)

As always, I enjoyed hearing the scientific along with the clinical factors that create success in everyday practice. My two brothers and I owe our implant success to the Misch brothers completely. They both showed us the way to successful practices with minimal complication. Thank god we found his brother Carl and eventually Craig in the beginning of our search for a teacher in 1985.

Shahdad Ayoughi - (1/6/2019 5:03 PM)

As usual, great presentation. Thanks Craig.

Craig Misch - (1/5/2019 8:15 PM)

Thank you David for the endorsement of the lecture - I created it special for the Dental XP meeting at NYU and the XP community. I appreciate the kind words from Dr. Kher - it was definitely a labor of love! Part 2 is more entertaining, I agree : )

UDATTA KHER - (1/4/2019 1:58 AM)

I had the privilege of watching this presentation at the XP NYU symposium. Craig I've heard you so often over the years. But that day you were sublime. I wish all clinicians practicing regenerative procedures watch this 2 part video.

David Garber - (1/2/2019 10:10 PM)

Dr Misch, this is a landmark elegant and sophisticated assessment of the convolution of regenerative techniques available to the clinician today . An honest evaluative program presented with your unique ability to communicate the information and then the integrity we value. An invaluable resource for clinically relevant decision making. . . . . We ALL appreciate it no end .

Craig Misch - (12/28/2018 11:46 AM)

Thank you for the kind comments D. Silva. I enjoyed your lecture and was impressed with the beautiful cases you showed. i look forward to crossing our paths again soon.

Robert Silva - (12/27/2018 3:48 PM)

Dear prof Craig Misch, I didn't have the opportunity to talk to you after our regeneration discussion following the lectures. It was a real honor and privilege to share the podium with you. You are not just a fantastic researcher, clinician and educator, but also a gentleman during the discussions. I learned so much from you. With all the respect Robert

Maurice Salama - (12/22/2018 12:56 PM)

One of the best modern day REGENERATION presentations EVER performed. Lot's we know and lot's we do not know still...scientifically based, THANK YOU!!!

Related Videos
Autologous Bone vs. Bioactive Modifiers/BMP-2: A Clinical Update in Bone Regeneration - Part 2 Premium Member Content

Autologous Bone vs. Bioactive Modifiers/BMP-2: A Clinical Update in Bone Regeneration - Part 2
There are several techniques and materials available for implant site development. The choice may depend on a number of factors including size of the defect, osseous morphology, costs and surgeon or patient preferences. Autogenous bone has long been considered the gold standard of graft materials. The trend today is to reduce patient morbidity but still provide predictable outcomes. This lecture will discuss the use of autogenous bone versus using bioactive modifiers such as platelet concentrates, rhPDGF and rhBMP-2 as replacement for the need to harvest bone.

Presented By:: Craig M Misch, DDS, MDS
Presentation Style: Video
Community Rating:
 
Watch Now>>
Implant Placement in the Posterior Mandible in Combination with Titanium Mesh and PRGF for Horizontal Bone Augmentation Premium Member Content

Implant Placement in the Posterior Mandible in Combination with Titanium Mesh and PRGF for Horizontal Bone Augmentation
Simultaneous implant placement and titanium mesh are utilized with mineralized irradiated bone allograft and PRGF to augment the deficient ridge form.

Presented By:: Maurice Salama, DMD
Presentation Style: Video
Community Rating:
 
Watch Now>>
Titanium Mesh GBR at the Time of Implant Placement in the Anterior Region part 1 of 2 Premium Member Content

Titanium Mesh GBR at the Time of Implant Placement in the Anterior Region part 1 of 2
This video details the management of a Titanium Mesh supported GBR procedure in the replacement of a Maxillary Central Incisor.

Presented By:: Tomohiro Ishikawa, DDS
Presentation Style: Video
Community Rating:
 
Watch Now>>
Related Courses
Autologous Bone vs. Bioactive Modifiers/BMP-2: A Clinical Update in Bone Regeneration - Part 2 of 2 Premium Member Content

Autologous Bone vs. Bioactive Modifiers/BMP-2: A Clinical Update in Bone Regeneration - Part 2 of 2
There are several techniques and materials available for implant site development. The choice may depend on a number of factors including size of the defect, osseous morphology, costs and surgeon or patient preferences. Autogenous bone has long been considered the gold standard of graft materials. The trend today is to reduce patient morbidity but still provide predictable outcomes. This lecture will discuss the use of autogenous bone versus using bioactive modifiers such as platelet concentrates, rhPDGF and rhBMP-2 as replacement for the need to harvest bone.

Presented By:: Craig M Misch, DDS, MDS
Presentation Style: Online Self-Study Course
CE Hours: 1 CEU (Continuing Eduication Credit)
Watch Now>>
Bone Augmentation & Bioengineering in the Clinical Implant Practice Premium Member Content

Bone Augmentation & Bioengineering in the Clinical Implant Practice
This webinar will introduce efficient and predictable bone graft solutions as well as bioactive modifiers that can be immediately incorporated into clinical practice.

Presented By:: Maurice Salama, DMD
Presentation Style: Online Self-Study Course
CE Hours: 1 CEU (Continuing Education Unit)
Watch Now>>
Tissue Engineering and Platelet Derived Growth Factors: Evidence Based Therapy Premium Member Content

Tissue Engineering and Platelet Derived Growth Factors: Evidence Based Therapy
Platelet derived growth factors are now routinely utilized in reconstructive therapy. This presentation describes very detailed and evidence based guidelines for clinicians interested in enhancing their abilities in tissue engineering, especially as it relates to bone augmentation.

Presented By:: Joseph Choukroun, MD
Presentation Style: Online Self-Study Course
CE Hours: 1
Watch Now>>
Related Articles
Physical And Chemical Properties Of Commercially Available Mineralized Bone Allograft

Physical And Chemical Properties Of Commercially Available Mineralized Bone Allograft
Bone graft materials are critical to the success of dental implants when there is a need to increase the volume of bone in a defect. The surface properties of these graft materials will have a profound impact on the outcome of the graft procedure. The clinician has many choices of bone graft substitutes when augmenting bony deficits. Allograft bone is the most widely used class of bone graft substitutes. Within this class there are a number of different bone allografts, which are manufactured utilizing widely varying processing techniques. There also appears to be a wide range of results in the published literature across the spectrum of different bone allografts. This in-vitro study evaluated chemical and surface properties of five different commercially available mineralized bone allografts.

Author(s): David C. Greenspan, Ph.D.
View Article>>
Subclassification and Clinical Management of Extraction Sockets with Labial Dentoalveolar Dehiscence Defects

Subclassification and Clinical Management of Extraction Sockets with Labial Dentoalveolar Dehiscence Defects
Immediate implant therapy involving implants placed into intact Type 1 extraction sockets has become a consistent clinical technique. The classification of Type 2 extraction sockets, where the mucosal tissues are present but there is a midfacial osseous dehiscence defect, has been described according to the extent of the buccal bone plate absence. The literature has offered different techniques in the treatment of Type 2 sockets; however, the extent of the defect has never been defined or delineated.

Author(s): Stephen J. Chu, DMD, MSD, CDT;Dennis P. Tarnow, DDS;Guido O. Sarnachiaro, DDS; Mark N. Hochman, DDS
View Article>>
Long Term Follow-Up of Dental Implants Placed in Autologous Onlay Bone Graft

Long Term Follow-Up of Dental Implants Placed in Autologous Onlay Bone Graft
The aim of this study was to evaluate the efficacy of autologous intraoral onlay bone grafting (OBG) in correlation with long-term survival rates of dental implants placed in the augmented bone. A retrospective study was conducted on 214 patients who received a total of 633 dental implants placed in 224 autologous intraoral block OBG augmentations, combined with Bio-Oss – mixed with platelet-rich plasma (PRP) and covered by platelet-poor plasma (PPP) – as scaffold, with a follow-up time up to 137 months. We suggest that augmentation of severely atrophied jaw bone through the placement of horizontal and/or vertical intraoral OBGs in combination with Bio-Oss saturated with PRP and covered by PPP should be considered a reliable, safe, and very effective surgical technique for obtaining high bone graft survival rate and high long-term implant survival rate.

Author(s): Devorah Schwartz-Arad, DMD, PhD;Ronen Ofec, DMD, MSc; Galit Eliyahu, PhD; Angela Ruban, PhD; Nir Sterer, DMD, PhD
View Article>>
Contact Us | Privacy Policy | Terms of Use
©2019

Preferred Language: English Flag
Contact Us · Login ·